ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Microorganisms in Vertebrate Digestive Systems
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1617288
Characterization of Gut Microbiota and Metabolites in Individuals with Constipation-Predominant Irritable Bowel Syndrome
Provisionally accepted
- First Hospital of Tsinghua University, Chaoyang, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: Constipation-predominant irritable bowel syndrome (IBS-C) is a prevalent functional gastrointestinal disorder with an incompletely understood pathogenesis.Recent studies have found that gut microbiota may contribute to its development. This study aimed to characterize the gut microbiota and associated metabolites in individuals with IBS-C to investigate potential pathogenic mechanisms.Methods: A total of 22 individuals diagnosed with IBS-C and 22 healthy controls were recruited at the First Hospital of Tsinghua University between January and December 2023. Stool samples were collected and subjected to metagenomic and metabolomic analyses to assess microbial composition and metabolic profiles.Bioinformatic analyses were employed to integrate and interpret the data.Results: Metagenomic sequencing results indicated no significant differences in overall gut microbial diversity between the IBS-C group and healthy individuals (p > 0.05). However, six bacterial species exhibited differential abundance. Notably, the relative abundance of beneficial taxa such as Megasphaera elsdenii, Bifidobacterium bifidum, and Alistipes inops was significantly reduced in the IBS-C group (p < 0.05).Metabolomic profiling demonstrated that differential metabolites were primarily enriched in pathways related to 3 short-chain fatty acids (SCFA) metabolism. SCFA levels were significantly downregulated in individuals with IBS-C, and a trend toward increased levels of the pro-inflammatory metabolite leukotriene D5 was observed.: Individuals with IBS-C demonstrate gut microbiota dysbiosis, characterized by reduced abundance of specific probiotic species and altered SCFA metabolism, along with potential low-grade inflammatory activity. These findings offer insights into the pathophysiological mechanisms of IBS-C and may inform the development of new therapeutic strategies.
Keywords: Gut Microbiota, irritable bowel syndrome of constipation, Metabolomics, Metagenomics, Gastroenterology
Received: 24 Apr 2025; Accepted: 21 Jul 2025.
Copyright: © 2025 Wang, Xu, Longmm and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yan-Li Cheng, First Hospital of Tsinghua University, Chaoyang, 100016, Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.